Ibuprofen/Acetaminophen Versus Nurofen Plus® and Panadeine® Extra Dental Pain Study
Status:
Completed
Trial end date:
2009-09-01
Target enrollment:
Participant gender:
Summary
The objective is to assess the efficacy and tolerability of a combination of 400 mg ibuprofen
plus 1000 mg acetaminophen, 200 mg ibuprofen plus 500 mg acetaminophen compared with Nurofen
Plus® and Panadeine® Extra.
Phase:
Phase 3
Details
Lead Sponsor:
Reckitt Benckiser LLC
Collaborators:
ACM Laboratories Aptuit Inc. Clearcut Clinical Consulting Premier Research Group plc Worldwide Clinical Trials